ArticleClinical diabetes and endocrinology2024

Does EFSA statement on Monacolin content of nutraceutical combinations impair their lipid lowering effect? The LopiGLIK experience.

Alessia Izzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.